Delivery Order SPE2DB20D3103-SPE2DB25FM6K6
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,030.03 firm fixed price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the requirements of the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
This is a $15,934.50 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4563282445 GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. No set-aside was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of glatiramer 40 mg/ml syringes. The contract has a potential value of $6,212.78 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) it holds with DLA valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,875.86 firm fixed-price delivery order is for the supply of Glatopa 40 mg/mL syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,502.90 firm fixed price contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a medical supply product. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Glatiramer 40 mg/ml syringes, a pharmaceutical product, with a potential value of $2,832.12. The contract is a firm fixed price delivery order with a completion date of January 5, 2024. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,340.83, is a Delivery Order for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,063.34 delivery order is for the supply of Glatopa 40 mg/mL syringes, a multiple sclerosis medication. The award is a firm fixed-price contract with an ultimate completion date of August 2, 2022. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,085.54 firm fixed-price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGE, a specialty medication. The award is a part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a...